Regulatory Expertise MDC Associates has a track record of delivering over 150 FDA submissions and managing more than 100 clinical studies, indicating strong regulatory and clinical capabilities that can be leveraged to win new diagnostic development programs seeking faster market authorization.

Diagnostics Focus Position MDC as a premier CRO partner for diagnostic innovators and in vitro diagnostic development, highlighting their specialization in regulatory strategy, clinical, and quality support to accelerate market-ready diagnostics.

Mid-market Headroom With 11-50 employees and annual revenue in the low-to-mid millions, MDC offers boutique, high-touch service with scalable support for startups and mid-sized biotech firms pursuing regulatory clearance without the overhead of larger firms.

Strategic Partnerships Leverage existing industry relationships and collaborative culture as a differentiator to pursue strategic alliances, co-development deals, or preferred provider arrangements with diagnostic developers seeking reliable regulatory pathways.

Industry Presence Recent participation in IDWeek 2025 signals active industry engagement; use events, case studies, and success stories as proof points to convert opportunities in the rapidly evolving diagnostic and regulatory landscapes.